Paracelsus Medizinische Privatuniversität (PMU)

Forschung & Innovation
Publikationen

New insights into possible HDAC inhibitor resistance in DLBCL - Comment on 'defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naïve resistance to pan-HDACi in diffuse large B cell lymphoma' by Havas et al

#2024
#TRANSLATIONAL ONCOLOGY

PMU Autor*innen
Tobias Kiesslich, Christian Mayr, Dino Bekric, Daniel Neureiter

Alle Autor*innen
Tobias Kiesslich, Christian Mayr, Dino Bekric, Daniel Neureiter

Fachzeitschrift
TRANSLATIONAL ONCOLOGY

Kurzfassung